Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. (TENX) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)

SC 13G/ATENXFiled Nov 12, 2026, 4:06 AM ET

About this filing

Tenax Therapeutics, Inc. (TENX) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Nov 12, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

View original filing on SEC.gov

Key facts

Document: —

More TENX filings

10-Q
Quarterly report
Filed Nov 5, 2026
8-K
Current report
Filed Nov 5, 2026
SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Oct 27, 2026
4
Insider transaction
Filed Oct 21, 2026
SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Oct 15, 2026
SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Oct 13, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.